Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates

ACS Nano

Volumn 6, Issue 5, 2012, Pages 3954-3966

  Tang, Li ^a   Fan, Timothy M ^b   Borst, Luke B ^c   Cheng, Jianjun ^a  

^a University of Illinois at Urbana Champaign   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Cancer therapy; Cell uptake; Chemotherapeutics; Drug delivery; Nanoconjugates; Nanomedicine; Nanoparticle biodistribution; Silica nanoparticle; Tumor penetration

Indexed keywords

CANCER THERAPY; CELL UPTAKE; CHEMOTHERAPEUTICS; NANOPARTICLE BIODISTRIBUTION; SILICA NANOPARTICLES; TUMOR PENETRATION;

DRUG DELIVERY; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; PARTICLE SIZE; SILICA; TUMORS;

NANOCONJUGATES;

DRUG; NANOCONJUGATE; SILICON DIOXIDE;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMISTRY; FEMALE; HELA CELL; HUMAN; KINETICS; MOUSE;

ANIMALS; FEMALE; HELA CELLS; HUMANS; KINETICS; MICE; MICE, INBRED C57BL; NANOCONJUGATES; PHARMACEUTICAL PREPARATIONS; SILICON DIOXIDE;

EID: 84864722016     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn300149c     Document Type: Article

References (67)

1. Duncan, R. Polymer Conjugates as Anticancer Nanomedicines. Nat. Rev. Cancer 2006, 6, 688-701.
2. Davis, M. E.; Chen, Z.; Shin, D. M. Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer. Nat. Rev. Drug Discovery 2008, 7, 771-782.
3. Ferrari, M. Cancer Nanotechnology: Opportunities and Challenges. Nat. Rev. Cancer 2005, 5, 161-171.
4. Pornpattananangkul, D.; Zhang, L.; Olson, S.; Aryal, S.; Obonyo, M.; Vecchio, K.; Huang, C. M.; Zhang, L. F. Bacterial Toxin-Triggered Drug Release from Gold Nanoparticle-Stabilized Liposomes for the Treatment of Bacterial Infection. J. Am. Chem. Soc. 2011, 133, 4132-4139.
5. Shim, M. S.; Kwon, Y. J. Acid-Transforming Polypeptide Micelles for Targeted Nonviral Gene Delivery. Biomaterials 2010, 31, 3404-3413.
6. Bae, J. W.; Pearson, R. M.; Patra, N.; Sunoqrot, S.; Vukovic, L.; Kral, P.; Hong, S. Dendron-Mediated Self-Assembly of Highly PEGylated Block Copolymers: A Modular Nanocarrier Platform. Chem. Commun. 2011, 47, 10302-10304.
7. Medina, S. H.; Tekumalla, V.; Chevliakov, M. V.; Shewach, D. S.; Ensminger, W. D.; El-Sayed, M. E. H. N-Acetylgalactosamine-Functionalized Dendrimers as Hepatic Cancer Cell-Targeted Carriers. Biomaterials 2011, 32, 4118-4129.
8. Bagalkot, V.; Farokhzad, O. C.; Langer, R.; Jon, S. An Aptamer-Doxorubicin Physical Conjugate as a Novel Targeted Drug-Delivery Platform. Angew. Chem., Int. Ed. 2006, 45, 8149-8152.
9. Ghadiali, J. E.; Lowe, S. B.; Stevens, M. M. Quantum-Dot-Based FRET Detection of Histone Acetyltransferase Activity. Angew. Chem., Int. Ed. 2011, 50, 3417-3420.
10. Wagner, V.; Dullaart, A.; Bock, A. K.; Zweck, A. The Emerging Nanomedicine Landscape. Nat. Biotechnol. 2006, 24, 1211-1217.
11. Stewart, S.; Jablonowski, H.; Goebel, F.; Arasteh, K.; Spittle, M.; Rios, A.; Aboulafia, D.; Galleshaw, J.; Dezube, B. Randomized Comparative Trial of PEGylated Liposomal Doxorubicin versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma. International PEGylated Liposomal Doxorubicin Study Group. J. Clin. Oncol. 1998, 16, 683-691.
12. Dreher, M. R.; Liu, W. G.; Michelich, C. R.; Dewhirst, M. W.; Yuan, F.; Chilkoti, A. Tumor Vascular Permeability, Accumulation, and Penetration of Macromolecular Drug Carriers. J. Natl. Cancer Inst. 2006, 98, 335-344.
13. Reddy, S. T.; van der Vlies, A. J.; Simeoni, E.; Angeli, V.; Randolph, G. J.; O'Neil, C. P.; Lee, L. K.; Swartz, M. A.; Hubbell, J. A. Exploiting Lymphatic Transport and Complement Activation in Nanoparticle Vaccines. Nat. Biotechnol. 2007, 25, 1159-1164.
14. Gratton, S. E. A.; Ropp, P. A.; Pohlhaus, P. D.; Luft, J. C.; Madden, V. J.; Napier, M. E.; De Simone, J. M. The Effect of Particle Design on Cellular Internalization Pathways. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 11613-11618.
15. Jiang, W.; Kim, B. Y. S.; Rutka, J. T.; Chan, W. C. W. Nanoparticle-Mediated Cellular Response Is Size-Dependent. Nat. Nanotechnol. 2008, 3, 145-150.
16. Mitragotri, S.; Lahann, J. Physical Approaches to Biomaterial Design. Nat. Mater. 2009, 8, 15-23.
17. Nel, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M. V.; Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M. Understanding Biophysicochemical Interactions at the Nano-Bio Interface. Nat. Mater. 2009, 8, 543-557.
18. Kim, B.; Han, G.; Toley, B. J.; Kim, C. K.; Rotello, V. M.; Forbes, N. S. Tuning Payload Delivery in Tumour Cylindroids Using Gold Nanoparticles. Nat. Nanotechnol. 2010, 5, 465-472.
19. Jin, Y.; Gao, X. Plasmonic Fluorescent Quantum Dots. Nat. Nanotechnol. 2009, 4, 571-576.
20. Farokhzad, O. C.; Cheng, J. J.; Teply, B. A.; Sherifi, I.; Jon, S.; Kantoff, P. W.; Richie, J. P.; Langer, R. Targeted Nanoparticle-Aptamer Bioconjugates for Cancer Chemotherapy in Vivo. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 6315-6320.
21. Smith, A. M.; Mohs, A. M.; Nie, S. Tuning the Optical and Electronic Properties of Colloidal Nanocrystals by Lattice Strain. Nat. Nanotechnol. 2009, 4, 56-63.
22. Decuzzi, P.; Godin, B.; Tanaka, T.; Lee, S. Y.; Chiappini, C.; Liu, X.; Ferrari, M. Size and Shape Effects in the Biodistribution of Intravascularly Injected Particles. J. Controlled Release 2010, 141, 320-327.
23. Yu, T.; Malugin, A.; Ghandehari, H. Impact of Silica Nanoparticle Design on Cellular Toxicity and Hemolytic Activity. ACS Nano 2011, 5, 5717-5728.
24. Wang, H.; Wang, S. T.; Su, H.; Chen, K. J.; Armijo, A. L.; Lin, W. Y.; Wang, Y. J.; Sun, J.; Kamei, K.; Czernin, J.; et al. A Supramolecular Approach for Preparation of Size-Controlled Nanoparticles. Angew. Chem., Int. Ed. 2009, 48, 4344-4348.
25. Perrault, S. D.; Walkey, C.; Jennings, T.; Fischer, H. C.; Chan, W. C. W. Mediating Tumor Targeting Efficiency of Nanoparticles through Design. Nano Lett. 2009, 9, 1909-1915.
26. Goodman, T. T.; Olive, P. L.; Pun, S. H. Increased Nanoparticle Penetration in Collagenase-Treated Multicellular Spheroids. Int. J. Nanomed. 2007, 2, 265-274.
27. Cabral, H.; Matsumoto, Y.; Mizuno, K.; Chen, Q.; Murakami, M.; Kimura, M.; Terada, Y.; Kano, M. R.; Miyazono, K.; Uesaka, M.; et al. Accumulation of Sub-100 nm Polymeric Micelles in Poorly Permeable Tumours Depends on Size. Nat. Nanotechnol. 2011, 6, 815-823.
28. Stober, W.; Fink, A.; Bohn, E. Controlled Growth of Monodisperse Silica Spheres in Micron Size Range. J. Colloid Interface Sci. 1968, 26, 62-69.
29. Stein, A.; Melde, B. J.; Schroden, R. C. Hybrid Inorganic-Organic Mesoporous Silicates;Nanoscopic Reactors Coming of Age. Adv. Mater. 2000, 12, 1403-1419.
30. 4 (M = Fe, Co, Mn) Nanoparticles. J. Am. Chem. Soc. 2004, 126, 273-279.
31. Caliceti, P.; Veronese, F. M. Pharmacokinetic and Biodistribution Properties of Poly (ethylene glycol)-Protein Conjugates. Adv. Drug Delivery Rev. 2003, 55, 1261-1277.
32. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor Vascular Permeability and the EPR Effect in Macromolecular Therapeutics: A Review. J. Controlled Release 2000, 65, 271-284.
33. Chithrani, B. D.; Chan, W. C. W. Elucidating the Mechanism of Cellular Uptake and Removal of Protein-Coated Gold Nanoparticles of Different Sizes and Shapes. Nano Lett. 2007, 7, 1542-1550.
34. O'Brien, M. E. R.; Wigler, N.; Inbar, M.; Rosso, R.; Grischke, E.; Santoro, A.; Catane, R.; Kieback, D. G.; Tomczak, P.; Ackland, S. P.; et al. Reduced Cardiotoxicity and Comparable Efficacy in a Phase III Trial of PEGylated Liposomal Doxorubicin Hcl (Caelyx/Doxil®) versus Conventional Doxorubicin for First-Line Treatment of Metastatic Breast Cancer. Ann. Oncol. 2004, 15, 440-449.
35. Finnie, K. S.; Waller, D. J.; Perret, F. L.; Krause-Heuer, A. M.; Lin, H. Q.; Hanna, J. V.; Barbe, C. J. Biodegradability of Sol-Gel Silica Microparticles for Drug Delivery. J. Sol-Gel Sci. Technol. 2009, 49, 12-18.
36. Park, J. H.; Gu, L.; von Maltzahn, G.; Ruoslahti, E.; Bhatia, S. N.; Sailor, M. J. Biodegradable Luminescent Porous Silicon Nanoparticles for In Vivo Applications. Nat. Mater. 2009, 8, 331-336.
37. Cho, M. J.; Cho, W. S.; Choi, M.; Kim, S. J.; Han, B. S.; Kim, S. H.; Kim, H. O.; Sheen, Y. Y.; Jeong, J. Y. The Impact of Size on Tissue Distribution and Elimination by Single Intravenous Injection of Silica Nanoparticles. Toxicol. Lett. 2009, 189, 177-183.
38. He, X. X.; Nie, H. L.; Wang, K. M.; Tan, W. H.; Wu, X.; Zhang, P. F. In Vivo Study of Biodistribution and Urinary Excretion of Surface-Modified Silica Nanoparticles. Anal. Chem. 2008, 80, 9597-9603.
39. Li, L. L.; Tang, F. Q.; Liu, H. Y.; Liu, T. L.; Hao, N. J.; Chen, D.; Teng, X.; He, J. Q. In Vivo Delivery of Silica Nanorattle Encapsulated Docetaxel for Liver Cancer Therapy with Low Toxicity and High Efficacy. ACS Nano 2010, 4, 6874-6882.
40. Della Rocca, J.; Huxford, R. C.; Comstock-Duggan, E.; Lin, W. Polysilsesquioxane Nanoparticles for Targeted Platin-Based Cancer Chemotherapy by Triggered Release. Angew. Chem., Int. Ed. 2011, 50, 10330-10334.
41. Unger, K.; Rupprecht, H.; Valentin, B.; Kircher, W. The Use of Porous and Surface Modified Silicas as Drug Delivery and Stabilizing Agents. Drug Dev. Ind. Pharm. 1983, 9, 69-91.
42. Wang, L.; Wang, K. M.; Santra, S.; Zhao, X. J.; Hilliard, L. R.; Smith, J. E.; Wu, J. R.; Tan, W. H. Watching Silica Nanoparticles Glow in the Biological World. Anal. Chem. 2006, 78, 646-654.
43. Benezra, M.; Penate-Medina, O.; Zanzonico, P. B.; Schaer, D.; Ow, H.; Burns, A.; De Stanchina, E.; Longo, V.; Herz, E.; Iyer, S.; et al. Multimodal Silica Nanoparticles Are Effective Cancer-Targeted Probes in a Model of Human Melanoma. J. Clin. Invest. 2011, 121, 2768-2780.
44. Yan, E. Y.; Fu, Y. L.; Wang, X.; Ding, Y.; Qian, H. Q.; Wang, C. H.; Hu, Y.; Jiang, X. Q. Hollow Chitosan-Silica Nanospheres for Doxorubicin Delivery to Cancer Cells with Enhanced Antitumor Effect in Vivo. J. Mater. Chem. 2011, 21, 3147-3155.
45. Jin, Y. H.; Lohstreter, S.; Pierce, D. T.; Parisien, J.; Wu, M.; Hall, C.; Zhao, J. X. J. Silica Nanoparticles with Continuously Tunable Sizes: Synthesis and Size Effects on Cellular Contrast Imaging. Chem. Mater. 2008, 20, 4411-4419.
46. Klichko, Y.; Liong, M.; Choi, E.; Angelos, S.; Nel, A. E.; Stoddart, J. F.; Tamanoi, F.; Zink, J. I. Mesostructured Silica for Optical Functionality, Nanomachines, and Drug Delivery. J. Am. Ceram. Soc. 2009, 92, S2-S10.
47. Xia, T. A.; Kovochich, M.; Liong, M.; Meng, H.; Kabehie, S.; George, S.; Zink, J. I.; Nel, A. E. Polyethyleneimine Coating Enhances the Cellular Uptake of Mesoporous Silica Nanoparticles and Allows Safe Delivery of SiRNA and DNA Constructs. ACS Nano 2009, 3, 3273-3286.
48. Meng, H. A.; Liong, M.; Xia, T. A.; Li, Z. X.; Ji, Z. X.; Zink, J. I.; Nel, A. E. Engineered Design of Mesoporous Silica Nanoparticles To Deliver Doxorubicin and P-Glycoprotein SiRNA To Overcome Drug Resistance in a Cancer Cell Line. ACS Nano 2010, 4, 4539-4550.
49. Meng, H.; Yang, S.; Li, Z. X.; Xia, T.; Chen, J.; Ji, Z. X.; Zhang, H. Y.; Wang, X.; Lin, S. J.; Huang, C.; et al. Aspect Ratio Determines the Quantity of Mesoporous Silica Nanoparticle Uptake by a Small GTPase-Dependent Macropinocytosis Mechanism. ACS Nano 2011, 5, 4434-4447.
50. Burns, A. A.; Vider, J.; Ow, H.; Herz, E.; Penate-Medina, O.; Baumgart, M.; Larson, S. M.; Wiesner, U.; Bradbury, M. Fluorescent Silica Nanoparticles with Efficient Urinary Excretion for Nanomedicine. Nano Lett. 2009, 9, 442-448.
51. Lai, C. Y.; Trewyn, B. G.; Jeftinija, D. M.; Jeftinija, K.; Xu, S.; Jeftinija, S.; Lin, V. S. Y. A Mesoporous Silica Nanosphere-Based Carrier System with Chemically Removable CdS Nanoparticle Caps for Stimuli-Responsive Controlled Release of Neurotransmitters and Drug Molecules. J. Am. Chem. Soc. 2003, 125, 4451-4459.
52. Giri, S.; Trewyn, B. G.; Stellmaker, M. P.; Lin, V. S. Y. Stimuli-Responsive Controlled-Release Delivery System Based on Mesoporous Silica Nanorods Capped with Magnetic Nanoparticles. Angew. Chem., Int. Ed. 2005, 44, 5038-5044.
53. Taylor, K. M. L.; Kim, J. S.; Rieter, W. J.; An, H.; Lin, W. L.; Lin, W. B. Mesoporous Silica Nanospheres as Highly Efficient MRI Contrast Agents. J. Am. Chem. Soc. 2008, 130, 2154-2155.
54. Rieter, W. J.; Kim, J. S.; Taylor, K. M. L.; An, H. Y.; Lin, W. L.; Tarrant, T.; Lin, W. B. Hybrid Silica Nanoparticles for Multimodal Imaging. Angew. Chem., Int. Ed. 2007, 46, 3680-3682.
55. Kim, J. S.; Rieter, W. J.; Taylor, K. M. L.; An, H.; Lin, W. L.; Lin, W. B. Self-Assembled Hybrid Nanoparticles for Cancer-Specific Multimodal Imaging. J. Am. Chem. Soc. 2007, 129, 8962-8963.
56. Barbe, C.; Bartlett, J.; Kong, L. G.; Finnie, K.; Lin, H. Q.; Larkin, M.; Calleja, S.; Bush, A.; Calleja, G. Silica Particles: A Novel Drug-Delivery System. Adv. Mater. 2004, 16, 1959-1966.
57. Hulchanskyy, T. Y.; Roy, I.; Goswami, L. N.; Chen, Y.; Bergey, E. J.; Pandey, R. K.; Oseroff, A. R.; Prasad, P. N. Organically Modified Silica Nanoparticles with Covalently Incorporated Photosensitizer for Photodynamic Therapy of Cancer. Nano Lett. 2007, 7, 2835-2842.
58. Torney, F.; Trewyn, B. G.; Lin, V. S. Y.; Wang, K. Mesoporous Silica Nanoparticles Deliver DNA and Chemicals into Plants. Nat. Nanotechnol. 2007, 2, 295-300.
59. Bharali, D. J.; Klejbor, I.; Stachowiak, E. K.; Dutta, P.; Roy, I.; Kaur, N.; Bergey, E. J.; Prasad, P. N.; Stachowiak, M. K. Organically Modified Silica Nanoparticles: A Nonviral Vector for In Vivo Gene Delivery and Expression in the Brain. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 11539-11544.
60. Lu, J.; Liong, M.; Zink, J. I.; Tamanoi, F. Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs. Small 2007, 3, 1341-1346.
61. Liong, M.; Angelos, S.; Choi, E.; Patel, K.; Stoddart, J. F.; Zink, J. I. Mesostructured Multifunctional Nanoparticles for Imaging and Drug Delivery. J. Mater. Chem. 2009, 19, 6251-6257.
62. Lu, J.; Liong, M.; Li, Z. X.; Zink, J. I.; Tamanoi, F. Biocompatibility, Biodistribution, and Drug-Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals. Small 2010, 6, 1794-1805.
63. Ferris, D. P.; Lu, J.; Gothard, C.; Yanes, R.; Thomas, C. R.; Olsen, J. C.; Stoddart, J. F.; Tamanoi, F.; Zink, J. I. Synthesis of Biomolecule-Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer Cells. Small 2011, 7, 1816-1826.
64. Hom, C.; Lu, J.; Liong, M.; Luo, H. Z.; Li, Z. X.; Zink, J. I.; Tamanoi, F. Mesoporous Silica Nanoparticles Facilitate Delivery of SiRNA To Shutdown Signaling Pathways in Mammalian Cells. Small 2010, 6, 1185-1190.
65. Corma, A.; Diaz, U.; Arrrica, M.; Fernandez, E.; Ortega, I. Organic-Inorganic Nanospheres with Responsive Molecular Gates for Drug Storage and Release. Angew. Chem., Int. Ed. 2009, 48, 6247-6250.
66. Kim, J. W.; Kim, L. U.; Kim, C. K. Size Control of Silica Nanoparticles and Their Surface Treatment for Fabrication of Dental Nanocomposites. Biomacromolecules 2007, 8, 215-222.
67. Ha, S. W.; Camalier, C. E.; Beck, G. R.; Lee, J. K. New Method To Prepare Very Stable and Biocompatible Fluorescent Silica Nanoparticles. Chem. Commun. 2009, 2881-2883.